Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGastroenterology Physician in Cincinnati, OH
NPI: 1144219957Primary Practice Location
Tri State Endoscopy Center
2925 Vernon Place, Cincinnati, OH
Primary Employer
Ohio GI & Liver Institute
cincygastro.com
HQ Phone
Get M.D. Mark's Phone Numberphone_androidMobile
Get M.D. Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 105 | 130 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 72 | 87 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 66 | 66 |
| 4 | 76705Ultrasound of abdomen, limited | 30 | 35 |
| 5 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 11 | 18 |
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.
Authors: Norman Gitlin, Joseph Odin, Hemant Shah, Christopher Bowlus, Bruce Bacon, Virginia Clark, Michael Galambos, John Vierling, Cynthia Levy
Publication Date: 2017-10
Durability of rifaximin response in hepatic encephalopathy.
Authors: Guy Neff
Publication Date: 2011-10-21
Authors: Guy Neff
Journal: J Clin Gastroenterol
Lead Sponsor: Manal Abdelmalek
Intervention / Treatment: DRUG: Placebo, DRUG: JKB-121: 5 mg twice daily, DRUG: JKB-121: 10 mg twice daily
